The path to a better Tuberculosis vaccine runs through Montana

A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other. The BCG (Bacille Calmette-Guérin) vaccine, created in 1921, remains the sole TB vaccine. While it is 40% to 80% effective in young children, its […] The post The path to a better Tuberculosis vaccine runs through Montana appeared first on Daily Montanan.

Related Keywords

Montana ,United States ,Chile ,University Of Montana ,Harvard University ,Massachusetts ,Boston ,Missoula ,Alemnew Dagnew ,Jay Evans ,Eric Harkleroad ,Bacille Calmette Gu ,Gates Medical Research Institute ,Health News ,Precision Vaccines Program At Boston Children Hospital ,University Of Montana Center ,Melinda Gates Medical Research Institute ,Montana Center ,Ofer Levy ,Precision Vaccines Program ,Boston Children ,Gates Medical Research ,Translational Medicine ,Ub Vaccine ,Immune Response ,Vaccine Research ,Accine Against Tuberculosis ,Immune System ,Adjuvants ,Bcg Vaccine ,Shingles Vaccine ,Infectious Disease ,Vaccines ,Adjuvant ,